M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

Operating Margin
MoonLake Immunotherapeutics

0%
Current
0%
Average
7.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-108.5m
/
Revenue
0

Operating Margin Across Competitors

Country CH
Market Cap 3.2B USD
Operating Margin N/A
Country CA
Market Cap 559.6B CAD
Operating Margin N/A
Country IN
Market Cap 31.3B INR
Operating Margin
8%
Country US
Market Cap 91.9B USD
Operating Margin
1%
Country NL
Market Cap 83B Zac
Operating Margin
61%
Country US
Market Cap 41.3B EUR
Operating Margin
1%
Country ID
Market Cap 688.9T IDR
Operating Margin
38%
Country US
Market Cap 23B USD
Operating Margin
-54%
Country CH
Market Cap 20.1B CHF
Operating Margin
15%
Country IN
Market Cap 1.9T INR
Operating Margin
68%
Country US
Market Cap 18.4B USD
Operating Margin
-9%

Profitability Report

View the profitability report to see the full profitability analysis for MoonLake Immunotherapeutics.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-108.5m
/
Revenue
0
What is the Operating Margin of MoonLake Immunotherapeutics?

Based on MoonLake Immunotherapeutics's most recent financial statements, the company has Operating Margin of 0%.